Premium
Reinforcer Pathology: The Behavioral Economics of Abuse Liability Testing
Author(s) -
Bickel WK,
Snider SE,
Quisenberry AJ,
Stein JS
Publication year - 2017
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.443
Subject(s) - abuse liability , behavioral economics , liability , reinforcement , substance abuse , psychology , drugs of abuse , cognitive psychology , actuarial science , medicine , neuroscience , drug , economics , psychiatry , social psychology , microeconomics , finance
Understanding the abuse liability of novel drugs is critical to understanding the risk these new compounds pose to society. Behavioral economics, the integration of psychology and economics, can be used to predict abuse liability of novel substances. Here, we describe the behavioral economic concept of reinforcer pathology and how it may predict the use of novel drugs in existing drug‐users and initiation of use in the drug‐naive.